{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:44:42Z","timestamp":1794350682138,"version":"4.9.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["336,234"],"award-info":[{"award-number":["336,234"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1201706"],"award-info":[{"award-number":["1201706"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012066","name":"Wings for Life Spinal Cord Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008191","name":"Wings for Life","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016968","name":"Fondo Nacional de Innovaci\u00f3n y Desarrollo Cient\u00edfico\u2013Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110618","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T15:37:19Z","timestamp":1753803439000},"page":"110618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Low-molecular weight protamine enhances neuroprotection and remyelination by mitigating chondroitin sulfate proteoglycan inhibition in models of demyelination"],"prefix":"10.1016","volume":"279","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-7687","authenticated-orcid":false,"given":"Tapani K.","family":"Koppinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9005-0313","authenticated-orcid":false,"given":"Carolina R.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-7906","authenticated-orcid":false,"given":"Liam","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhan","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas A.E.","family":"Kallionp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4351-9212","authenticated-orcid":false,"given":"Saila Medina","family":"Leskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0617-7109","authenticated-orcid":false,"given":"Nadine","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0959-2957","authenticated-orcid":false,"given":"Annakaisa","family":"Haapasalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7895-6318","authenticated-orcid":false,"given":"Francisco J.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja H.","family":"Voutilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Rauvala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110618_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","article-title":"Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models","volume":"125","author":"Boyd","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2025.110618_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0049-3848(98)00201-1","article-title":"Low molecular weight protamine: a potential nontoxic heparin antagonist","volume":"94","author":"Byun","year":"1999","journal-title":"Thromb. Res."},{"key":"10.1016\/j.neuropharm.2025.110618_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1128-2","article-title":"Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTP\u03c3 receptors promotes a beneficial inflammatory response following spinal cord injury","volume":"15","author":"Dyck","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2025.110618_bib4","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1523\/JNEUROSCI.2900-16.2017","article-title":"2-Arachidonoylglycerol reduces proteoglycans and enhances remyelination in a progressive model of demyelination","volume":"37","author":"Feli\u00fa","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110618_bib5","first-page":"1","article-title":"Chondroitin sulfate proteoglycans prevent immune cell phenotypic conversion and inflammation resolution via TLR4 in rodent models of spinal cord injury","author":"Francos-Quijorna","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110618_bib6","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS remyelination and inflammation: from basic mechanisms to therapeutic opportunities","volume":"110","author":"Franklin","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2025.110618_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neuropharm.2025.110618_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-30032-0","article-title":"Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination","volume":"13","author":"Ghorbani","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110618_bib9","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/awab059","article-title":"The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis","volume":"144","author":"Ghorbani","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2025.110618_bib10","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1523\/JNEUROSCI.0219-10.2010","article-title":"Elevated phosphatidylinositol 3,4,5-Trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination","volume":"30","author":"Goebbels","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110618_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2014.05.056","article-title":"Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide","volume":"193","author":"He","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.neuropharm.2025.110618_bib12","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.ajpath.2012.07.011","article-title":"Accelerated axonal loss following acute CNS demyelination in mice lacking protein tyrosine phosphatase receptor type Z","volume":"181","author":"Huang","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110618_bib13","first-page":"1","article-title":"An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination","volume":"71","author":"Keough","year":"2016","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110618_bib14","first-page":"1","article-title":"An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination","volume":"71","author":"Keough","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110618_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41582-023-00801-6","article-title":"Inflammation in multiple sclerosis: consequences for remyelination and disease progression","volume":"195 19","author":"Klotz","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110618_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189164","article-title":"Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation","volume":"12","author":"Kuboyama","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110618_bib17","doi-asserted-by":"crossref","first-page":"E1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2025.110618_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.865275","article-title":"Low-molecular weight protamine overcomes chondroitin sulfate inhibition of neural regeneration","volume":"10","author":"Kulesskaya","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"7539","key":"10.1016\/j.neuropharm.2025.110618_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature13974","article-title":"Modulation of the proteoglycan receptor PTP\u03c3 promotes recovery after spinal cord injury","volume":"518","author":"Lang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110618_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.23599","article-title":"Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination","volume":"72","author":"Lau","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110618_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainresbull.2021.05.004","article-title":"CSPGs promote the migration of meningeal fibroblasts via p38 mitogen-activated protein kinase signaling pathway under OGD conditions","volume":"173","author":"Li","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2025.110618_bib22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","article-title":"The pro-remyelination properties of microglia in the central nervous system","volume":"15","author":"Lloyd","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110618_bib23","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/brain\/122.12.2279","article-title":"A quantitative analysis of oligodendrocytes in multiple sclerosis lesions: a study of 113 cases","volume":"122","author":"Lucchinetti","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2025.110618_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06505-6","article-title":"Modulation of proteoglycan receptor PTP\u03c3 enhances MMP-2 activity to promote recovery from multiple sclerosis","volume":"9","author":"Luo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110618_bib25","article-title":"In vitro assessment of protamine toxicity with neural cells, its therapeutic potential to counter chondroitin sulfate mediated neuron inhibition, and its effects on reactive astrocytes","volume":"7","author":"Nelson","year":"2024","journal-title":"Adv. Ther."},{"key":"10.1016\/j.neuropharm.2025.110618_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","article-title":"Metformin restores CNS remyelination capacity by rejuvenating aged stem cells","volume":"25","author":"Neumann","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuropharm.2025.110618_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/srep33916","article-title":"HB-GAM (Pleiotrophin) reverses inhibition of neural regeneration by the CNS extracellular matrix","volume":"6","author":"Paveliev","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2025.110618_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.expneurol.2013.04.003","article-title":"Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTP\u03c3","volume":"247","author":"Pendleton","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110618_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd.2017.115","article-title":"Remyelination therapies: a new direction and challenge in multiple sclerosis","volume":"16","author":"Plemel","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2025.110618_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/glia.23245","article-title":"Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy","volume":"66","author":"Plemel","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2025.110618_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.neuropharm.2025.110618_bib32","first-page":"1","article-title":"Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model","volume":"71","author":"Romanelli","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2025.110618_bib33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51406","article-title":"Proteome profile of peripheral myelin in healthy mice and in a neuropathy model","volume":"9","author":"Siems","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2025.110618_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrn3898","article-title":"Astrocyte barriers to neurotoxic inflammation","volume":"16","author":"Sofroniew","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110618_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104674","article-title":"Fibrotic scar after experimental autoimmune encephalomyelitis inhibits oligodendrocyte differentiation","volume":"134","author":"Yahn","year":"2020","journal-title":"Neurobiol. Dis."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:12:02Z","timestamp":1780027922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"alternative-id":["S0028390825003260"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110618","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-molecular weight protamine enhances neuroprotection and remyelination by mitigating chondroitin sulfate proteoglycan inhibition in models of demyelination","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110618"}}